TGFB1 and breast cancer: Recent studies have found that emodin can block the TGF-β1-mediated crosstalk between TAMS and breast cancer cells, inhibit the epithelial cell transformation of breast cancer cells and the formation of cancer stem cells (Liu et al., 2020).